118 related articles for article (PubMed ID: 19560596)
21. Early bactericidal activity of a moxifloxacin and isoniazid combination in smear-positive pulmonary tuberculosis.
Gillespie SH; Gosling RD; Uiso L; Sam NE; Kanduma EG; McHugh TD
J Antimicrob Chemother; 2005 Dec; 56(6):1169-71. PubMed ID: 16223939
[TBL] [Abstract][Full Text] [Related]
22. PA-824 , moxifloxacin and pyrazinamide combination therapy for tuberculosis.
Dawson R; Diacon A
Expert Opin Investig Drugs; 2013 Jul; 22(7):927-32. PubMed ID: 23687915
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of time to detection of Mycobacterium tuberculosis in broth culture as a determinant for end points in treatment trials.
Weiner M; Prihoda TJ; Burman W; Johnson JL; Goldberg S; Padayatchi N; Duran P; Engle M; Muzanye G; Mugerwa RD; Sturm AW
J Clin Microbiol; 2010 Dec; 48(12):4370-6. PubMed ID: 20926712
[TBL] [Abstract][Full Text] [Related]
24. A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis.
Rustomjee R; Lienhardt C; Kanyok T; Davies GR; Levin J; Mthiyane T; Reddy C; Sturm AW; Sirgel FA; Allen J; Coleman DJ; Fourie B; Mitchison DA;
Int J Tuberc Lung Dis; 2008 Feb; 12(2):128-38. PubMed ID: 18230244
[TBL] [Abstract][Full Text] [Related]
25. Moxifloxacin for tuberculosis.
Singh KP; Brown M; Murphy ME; Gillespie SH
Lancet Infect Dis; 2012 Mar; 12(3):176; author reply 177-8. PubMed ID: 22361420
[No Abstract] [Full Text] [Related]
26. Moxifloxacin for tuberculosis.
Mendel C; Springsklee M
Lancet Infect Dis; 2012 Mar; 12(3):176-7; author reply 177-8. PubMed ID: 22361419
[No Abstract] [Full Text] [Related]
27. Rational use of moxifloxacin for tuberculosis treatment.
Cox H; Ford N; Keshavjee S; McDermid C; von Schoen-Angerer T; Mitnick C; Goemaere E
Lancet Infect Dis; 2011 Apr; 11(4):259-60. PubMed ID: 21453864
[No Abstract] [Full Text] [Related]
28. [Abstracts of 8th Moxifloxacin Research Workshop. November 17-18, 2012. Leverkusen, Germany].
Infection; 2012 Aug; 40 Suppl 1():1-71. PubMed ID: 22936293
[No Abstract] [Full Text] [Related]
29. Moxifloxacin.
Tuberculosis (Edinb); 2008 Mar; 88(2):127-31. PubMed ID: 18486050
[No Abstract] [Full Text] [Related]
30. Safety of fluoroquinolone use in patients with hepatotoxicity induced by anti-tuberculosis regimens.
Ho CC; Chen YC; Hu FC; Yu CJ; Yang PC; Luh KT
Clin Infect Dis; 2009 Jun; 48(11):1526-33. PubMed ID: 19400686
[TBL] [Abstract][Full Text] [Related]
31. Fluoroquinolones in the treatment of tuberculosis: which is best?
Schluger NW
Am J Respir Crit Care Med; 2013 Oct; 188(7):768-9. PubMed ID: 24083858
[No Abstract] [Full Text] [Related]
32. Drug combo speeds up TB treatment.
AIDS Patient Care STDS; 2007 Oct; 21(10):783-4. PubMed ID: 17949277
[No Abstract] [Full Text] [Related]
33. Sputum culture conversion with moxifloxacin-containing regimens in the treatment of patients with newly diagnosed sputum-positive pulmonary tuberculosis in South India.
Velayutham BV; Allaudeen IS; Sivaramakrishnan GN; Perumal V; Nair D; Chinnaiyan P; Paramasivam PK; Dhanaraj B; Santhanakrishnan RK; Navaneethapandian GP; Marimuthu MK; Kumar V; Kandasamy C; Dharuman K; Elangovan T; Narasimhan M; Rathinam S; Vadivelu G; Rathinam P; Chockalingam C; Jayabal L; Swaminathan S; Shaheed JM
Clin Infect Dis; 2014 Nov; 59(10):e142-9. PubMed ID: 25028463
[TBL] [Abstract][Full Text] [Related]
34. Extensively drug-resistant tuberculosis.
Dheda K; Shean K; Badri M
N Engl J Med; 2008 Nov; 359(22):2390; author reply 2391. PubMed ID: 19038886
[No Abstract] [Full Text] [Related]
35. Extensively drug resistance (XDR) tb is not always fatal.
Jain NK; Agnihotri SP; Sharma KK; Gupta S; Gupta P
Indian J Tuberc; 2009 Jan; 56(1):48-50. PubMed ID: 19402272
[TBL] [Abstract][Full Text] [Related]
36. Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium.
Bermudez LE; Inderlied CB; Kolonoski P; Petrofsky M; Aralar P; Wu M; Young LS
Antimicrob Agents Chemother; 2001 Jan; 45(1):217-22. PubMed ID: 11120969
[TBL] [Abstract][Full Text] [Related]
37. Moxifloxacin as an alternative or additive therapy for treatment of pulmonary tuberculosis.
Fouad M; Gallagher JC
Ann Pharmacother; 2011 Nov; 45(11):1439-44. PubMed ID: 21990937
[TBL] [Abstract][Full Text] [Related]
38. Comparative roles of moxifloxacin and levofloxacin in the treatment of pulmonary multidrug-resistant tuberculosis: a retrospective study.
Jiang RH; Xu HB; Li L
Int J Antimicrob Agents; 2013 Jul; 42(1):36-41. PubMed ID: 23582696
[TBL] [Abstract][Full Text] [Related]
39. Diagnosis and management of tuberculosis.
Harris AA; Karakusis P
Prim Care; 1979 Mar; 6(1):43-62. PubMed ID: 111269
[No Abstract] [Full Text] [Related]
40. Results of treatment with ethambutol and capreomycin in chronic pulmonary tuberculosis.
Kozakow H; Potworowska M; Janowiec M; Klimkiewicz H; Niemirowski J; Pszonicka A; Pecyna-Sielewicz J; Polaczek E; Rykowska Z; Frenkel A
Pol Med J; 1970; 9(4):876-85. PubMed ID: 4991068
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
